Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma, Kaposi 1Sarcoma 1Neoplasms 1Nasopharyngeal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Hodgkin Disease 1Castleman Disease 1

Interventions

Fluorodeoxyglucose F18 3Oncolytic Virotherapy 2Magnetic Resonance Spectroscopy 2Cisplatin 2weifuchun 1sodium thiosulfate 1s-formylglutathione hydrolase 1lenvatinib 1gallium 68 PSMA-11 1X-Rays 1Vitamins 1Trastuzumab 1Specimen Handling 1Radiation 1Platinum 1Oxaliplatin 1Nelfinavir 1Hyperthermic Intraperitoneal Chemotherapy 1Fluorouracil 1FAPI-46 1Esomeprazole 1Epirubicin 1Drug Therapy, Combination 1Doxorubicin 1Cytoreduction Surgical Procedures 1Carbohydrates 1Amoxicillin 168Ga-DKFZ-PSMA-11 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Stomach Neoplasms × Nelfinavir × Clear all
NCT02080416 2016-06-10

Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Terminated
1 enrolled
GastrointestinalHead & NeckLymphoidSarcoma

Castleman Disease, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Neoplasms, Sarcoma, Sarcoma, Kaposi, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡